Left Ventricular Thrombi: Insights from Cardiac Magnetic Resonance Imaging
- PMID: 34065998
- PMCID: PMC8162548
- DOI: 10.3390/tomography7020016
Left Ventricular Thrombi: Insights from Cardiac Magnetic Resonance Imaging
Abstract
Objective: Cardiovascular magnetic resonance imaging (CMR) late gadolinium enhancement technique (LGE) detects thrombus rather than anatomical presence based on tissue properties and is theoretically highly accurate. The present study's goal was to compare the diagnostic accuracy obtained with various CMR techniques and transthoracic echocardiography to diagnose left ventricular thrombus and evaluate the prevalence and perspectives of left ventricular (LV) thrombus among patients with impaired systolic left ventricular function. Methods: In a single academic referral center, a retrospective database review of all CMR assessments of the established left ventricular thrombus was carried out in 206 consecutive patients with reduced systolic function for five years. To assess thrombus risk factors, clinical and imaging parameters were analyzed. Sensitivity, specificity, negative predictive value (NPV), positive predictive value (PPV), echocardiography, and cine-CMR sequence accuracy have been identified. LV structural parameters were quantified to detect markers for thrombus and predictors of the additive usefulness of contrast-enhanced thrombus imaging. Comparisons against LGE-CMR were made, which was used as the standard. Results: A 7.8 percent prevalence of left ventricular thrombus was identified by LGE-CMR. Cine-CMR increased the diagnostic efficiency for echocardiographic thrombus identification in this group, with sensitivity increasing from 50 percent by echocardiography to 75 percent by cine-CMR (p = 0.008). Dark blood CMR (DB-CMR) has better sensitivity and accuracy than echocardiography (p < 0.001), comparable to cine-CMR. The transmural infarct size was an independent marker for thrombus after correction for the LVEF and LV volume while considering only CMR parameters. There were significantly higher embolic events (HR = 71.33; CI 8.31-616.06, p < 0.0001) in LV thrombus patients detected by LGE-CMR. Conclusion: CMR imaging was more sensitive to left ventricular thrombi identification compared with transthoracic echocardiography. An additional parameter available from LGE-CMR and shown as an independent risk factor for left ventricular thrombus is the myocardial scar.
Keywords: cardiac MRI; late gadolinium enhancement; left ventricular thrombi.
Conflict of interest statement
The authors declare no conflict of interest.
Figures




Similar articles
-
Long-Term Embolic Outcomes After Detection of Left Ventricular Thrombus by Late Gadolinium Enhancement Cardiovascular Magnetic Resonance Imaging: A Matched Cohort Study.Circ Cardiovasc Imaging. 2019 Nov;12(11):e009723. doi: 10.1161/CIRCIMAGING.119.009723. Epub 2019 Nov 11. Circ Cardiovasc Imaging. 2019. PMID: 31707810 Free PMC article.
-
Contrast-enhanced anatomic imaging as compared to contrast-enhanced tissue characterization for detection of left ventricular thrombus.JACC Cardiovasc Imaging. 2009 Aug;2(8):969-79. doi: 10.1016/j.jcmg.2009.03.017. JACC Cardiovasc Imaging. 2009. PMID: 19679285 Free PMC article.
-
Echocardiographic Algorithm for Post-Myocardial Infarction LV Thrombus: A Gatekeeper for Thrombus Evaluation by Delayed Enhancement CMR.JACC Cardiovasc Imaging. 2016 May;9(5):505-15. doi: 10.1016/j.jcmg.2015.06.017. Epub 2015 Oct 14. JACC Cardiovasc Imaging. 2016. PMID: 26476503 Free PMC article.
-
Cardiac MRI in Autoimmune Diseases: Where Are We Now?Curr Cardiol Rev. 2021;17(5):e160721190002. doi: 10.2174/1573403X16666210108104236. Curr Cardiol Rev. 2021. PMID: 33423649 Free PMC article. Review.
-
A systematic review and meta-analysis of transthoracic echocardiogram vs. cardiac magnetic resonance imaging for the detection of left ventricular thrombus.Eur Heart J Imaging Methods Pract. 2023 Dec 7;1(2):qyad041. doi: 10.1093/ehjimp/qyad041. eCollection 2023 Sep. Eur Heart J Imaging Methods Pract. 2023. PMID: 39045058 Free PMC article. Review.
Cited by
-
Different Oral Antithrombotic Therapy for the Treatment of Ventricular Thrombus: An Observational Study from 2010 to 2019.Int J Clin Pract. 2022 Feb 24;2022:7400860. doi: 10.1155/2022/7400860. eCollection 2022. Int J Clin Pract. 2022. PMID: 35685496 Free PMC article.
-
Characteristics of Novel Anticoagulants versus Vitamin K Antagonists in the Ventricular Mural Thrombus.Rev Cardiovasc Med. 2023 Mar 2;24(3):74. doi: 10.31083/j.rcm2403074. eCollection 2023 Mar. Rev Cardiovasc Med. 2023. PMID: 39077494 Free PMC article.
-
Predicting Thromboembolism in Hospitalized Patients with Ventricular Thrombus.Rev Cardiovasc Med. 2022 Nov 30;23(12):390. doi: 10.31083/j.rcm2312390. eCollection 2022 Dec. Rev Cardiovasc Med. 2022. PMID: 39076670 Free PMC article.
-
A Modified Classification Scheme for Chagas Cardiomyopathy Incorporating Cardiac Magnetic Resonance Imaging.Cureus. 2024 May 8;16(5):e59900. doi: 10.7759/cureus.59900. eCollection 2024 May. Cureus. 2024. PMID: 38854227 Free PMC article.
-
Massive Left Ventricular Thrombus Causing Bilateral Posterior Cerebral Artery Stroke: A Case Report and Review of Literature.Cureus. 2022 Aug 1;14(8):e27585. doi: 10.7759/cureus.27585. eCollection 2022 Aug. Cureus. 2022. PMID: 36059347 Free PMC article.
References
-
- Gottdiener J.S., Massie B., Ammons S.B., Egher C. Prevalence of left ventricular thrombus in dilated cardiomyopathy: The WATCH trial (abstr) J. Am. Coll. Cardiol. 2003;41:202A. doi: 10.1016/S0735-1097(03)81966-6. - DOI
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous